Trauma and psychotic experiences: transnational data from the World Mental Health Survey

John J McGrath¹, Sukanta Saha², Carmen C W Lim², Sergio Aguilar-Gaxiola², Jordi Alonso², Laura H Andrade², Evelyn J Bromet², Ronny Bruffaerts², José M Caldas de Almeida², Graça Cardoso², Giovanni de Girolamo², John Fayyad², Silvia Florescu², Oye Gureje², Josep M Haro², Norito Kawakami², Karestan C Koenen², Viviane Kovess-Masfety², Sing Lee², Jean-Pierre Lepine², Katie A McLaughlin², Maria E Medina-Mora², Fernando Navarro-Mateu², Akin Ojagbemi², Jose Posada-Villa², Nancy Sampson², Kate M Scott², Hisateru Tachimori², Margreet Ten Have², Kenneth S Kendler², Ronald C Kessler²; WHO World Mental Health Survey Collaborators

Affiliations

¹ John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology - LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) - St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA j.mcgrath@uq.edu.au.
² John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology - LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) - St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.

PMID: 29097400
PMCID: PMC5709675
DOI: 10.1192/bjp.bp.117.205955

Trauma and psychotic experiences: transnational data from the World Mental Health Survey

John J McGrath et al. Br J Psychiatry. 2017 Dec.

. 2017 Dec;211(6):373-380.

doi: 10.1192/bjp.bp.117.205955. Epub 2017 Nov 2.

Authors

Affiliations

¹ John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology - LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) - St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA j.mcgrath@uq.edu.au.
² John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology - LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) - St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057 Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S 1144, Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.

PMID: 29097400
PMCID: PMC5709675
DOI: 10.1192/bjp.bp.117.205955

Abstract

BackgroundTraumatic events are associated with increased risk of psychotic experiences, but it is unclear whether this association is explained by mental disorders prior to psychotic experience onset.AimsTo investigate the associations between traumatic events and subsequent psychotic experience onset after adjusting for post-traumatic stress disorder and other mental disorders.MethodWe assessed 29 traumatic event types and psychotic experiences from the World Mental Health surveys and examined the associations of traumatic events with subsequent psychotic experience onset with and without adjustments for mental disorders.ResultsRespondents with any traumatic events had three times the odds of other respondents of subsequently developing psychotic experiences (OR = 3.1, 95% CI 2.7-3.7), with variability in strength of association across traumatic event types. These associations persisted after adjustment for mental disorders.ConclusionsExposure to traumatic events predicts subsequent onset of psychotic experiences even after adjusting for comorbid mental disorders.

PubMed Disclaimer

Conflict of interest statement

Declaration of interestIn the past 3 years, R.C.K. received support for his epidemiological studies from Sanofi Aventis, was a consultant for Johnson & Johnson Wellness and Prevention, and served on an advisory board for the Johnson & Johnson Services Inc Lake Nona Life Project. He is a co-owner of DataStat, Inc, a market research firm that carries out healthcare research.

References

1. Trotta A, Murray RM, Fisher HL. The impact of childhood adversity on the persistence of psychotic symptoms: a systematic review and meta-analysis. Psychol Med 2015; 45: 2481–98. - PubMed
1. McGrath JJ, McLaughlin KA, Saha S, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, et al. The association between childhood adversities and subsequent first onset of psychotic experiences: a cross-national analysis of 23 998 respondents from 17 countries. Psychol Med 2017; 47: 1230–45. - PMC - PubMed
1. Beards S, Gayer-Anderson C, Borges S, Dewey ME, Fisher HL, Morgan C. Life events and psychosis: a review and meta-analysis. Schizophr Bull 2013; 39: 740–7. - PMC - PubMed
1. Kelleher I, Harley M, Lynch F, Arseneault L, Fitzpatrick C, Cannon M. Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample. Br J Psychiatry 2008; 193:378–82. - PubMed
1. Spauwen J, Krabbendam L, Lieb R, Wittchen H-u, van OS J. impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness. Br J Psychiatry 2006; 188: 527–33. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Trauma and psychotic experiences: transnational data from the World Mental Health Survey

Affiliations

Trauma and psychotic experiences: transnational data from the World Mental Health Survey

Authors

Affiliations

Abstract

Conflict of interest statement

References

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical